Investigating how lipid-based nanoparticles can effectively deliver RNA therapeutics.
Endosomal escape of lipid-based nanoparticles comprising Gaussian curvature lipids
This study is looking at new ways to help tiny particles deliver RNA medicines more effectively into cells, which could be helpful for treating diseases like COVID-19 and some cancers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-11057703 on NIH RePORTER |
What this research studies
This research focuses on improving the delivery of RNA therapeutics, which are promising for treating various diseases, including COVID-19 and certain cancers. The team is exploring lipid-based nanoparticles (LNPs) that can enter cells and release their RNA payloads effectively. By studying the fusion of these nanoparticles with cell membranes, the researchers aim to enhance the efficiency of RNA delivery. This involves understanding the physical properties of the nanoparticles and how they interact with cellular structures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic infections, genetic disorders, or cancers who may benefit from RNA therapeutics.
Not a fit: Patients with conditions that do not involve RNA therapeutics or those not eligible for clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective RNA-based treatments for diseases like COVID-19 and cancer.
How similar studies have performed: Previous research has shown promise in using lipid-based nanoparticles for RNA delivery, indicating a potential for success in this approach.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Leal, Cecilia Maria — University of Illinois at Urbana-Champaign
- Study coordinator: Leal, Cecilia Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.